UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

______________


FORM 8-K


CURRENT REPORT


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934



Date of report (Date of earliest event reported):  March 8, 2012


BIODEL INC.
(Exact name of registrant as specified in its charter)



Commission File Number 001-33451


 

 

 

Delaware
(State or other jurisdiction of incorporation or organization)

 

90-0136863
(IRS Employer Identification Number)

 

 

 

100 Saw Mill Road

Danbury, Connecticut

(Address of principal executive offices)

 


06810

(Zip code)



(203) 796-5000

(Registrant's telephone number, including area code)



Not Applicable

(Former Name or Former Address, if Changed Since Last Report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


[  ]

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Item 5.07

Submission of Matters to a Vote of Security Holders.


On March 8, 2012, Biodel Inc. (the "Company") held its 2012 annual meeting of stockholders at the Company’s headquarters in Danbury, Connecticut (the “Annual Meeting”).  At the Annual Meeting, Daniel Lorber, Brian J.G. Pereira and Charles Sanders were elected as Class II Directors, each for three-year terms, until the 2015 annual meeting of stockholders or until their respective successors are elected and qualified. At the Annual Meeting, the stockholders also (i) voted to approve an amendment to the Company’s 2010 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder solely for the purpose of allowing the Company to issue an aggregate of 1,096,756 restricted stock units to certain of our named executive officers and other employees in place of an aggregate of $822,567 in discretionary cash bonuses in connection with the fiscal year ended September 30, 2011; (ii) voted to approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation to effect a one-for-two reverse stock split of the Company’s issued and outstanding shares of common stock and to fix on a post-split basis the number authorized shares of common stock at 50,000,000 shares, such amendment to be effected prior to the Company’s next annual meeting of stockholders in the sole discretion of the Company’s board of directors (iii) voted to approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation to effect a one-for-four reverse stock split of the Company’s issued and outstanding shares of common stock and to fix on a post-split basis the number authorized shares of common stock at 25,000,000 shares, such amendment to be effected prior to the Company’s next annual meeting of stockholders in the sole discretion of the Company’s board of directors; and (iv) voted to ratify the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2012. The tabulation of the voting results is as follows:


Agenda Item 1:  Election of Directors


Nominees

For

Withheld

Broker Non-Votes

Daniel Lorber

13,324,890

801,299

16,026,330

Brian J.G. Pereira

12,158,120

1,968,069

16,026,330

Charles Sanders

13,368,660

757,529

16,026,330


Agenda Item 2:  Amendment to 2010 Stock Incentive Plan


For

Against

Abstain

Broker Non-Votes

11,920,734

1,993,802

211,653

16,026,330


Agenda Item 3:  One-for-Two Reverse Stock Split


For

Against

Abstain

28,290,400

1,652,756

209,363



Agenda Item 4:  One-for-Four Reverse Stock Split


For

Against

Abstain

27,905,384

1,926,469

320,666


Agenda Item 5:  Ratification of Appointment of Independent Registered Public Accounting Firm


For

Against

Abstain

29,174,070

579,700

398,749





2



 

SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



Date:

March 13, 2012

BIODEL INC.



By:  /s/ Paul S. Bavier                                        

       Paul S. Bavier, General Counsel






3